EILEEN M. MAHONEY, PH.D.

EDUCATION

Ph.D. Genetics (Chemical Carcinogenesis), Michigan State University, 1981
B.A. Biology, cum laude, State University of New York at Buffalo (UB), 1974

HONORS AND AWARDS

President, Society for Risk Analysis, Philadelphia Chapter, 1993
Secretary/Treasurer, Society for Risk Analysis, Philadelphia Chapter, 1999
Co-chair, Membership Committee, Society for Women Environmental Professionals, 1998, 1999
National Merit Scholar Letter of Commendation
New York State Regents’ Scholarship
Aspen Institute Young Executive

PROFESSIONAL EXPERIENCE

RESPONSIBILITIES

• Manage and direct all technical and business aspects of this consulting firm, which specializes in toxicological evaluations and human health risk assessments of chemical exposures.

• Conduct human health risk assessments under CERCLA, RCRA, CAA, and state environmental statutes to establish the human health impacts of chemical contamination in environmental media, and to determine media cleanup targets which are protective of human health.

• Conduct technical reviews of human health risk assessment documents for USEPA and state environmental agencies, in order to ensure consistency with established methodologies and their technical accuracy in matters relating to toxicology and human health risk assessment. The technical reviews are performed on documents submitted to the USEPA by regulated parties to satisfy requirements under federal and state environmental statutes.

• Serve as an expert witness for USEPA Regions 1, 3, 4, and 5, the Pennsylvania Department of Environmental Protection, and the Massachusetts DEP in the areas of Toxicology and Human Health Risk Assessment in litigations involving hazardous waste remediation.

• Negotiate with EPA and state environmental agencies for clients on technical issues associated with Toxicology and Human Health Risk Assessments, ensuring that Agency judgments are made on sound science.

• Serve as an expert witness in the areas of Toxicology and Human Health Risk Assessment in toxic tort litigations.

• Present results of human health risk assessments to the impacted community, in open forums, where the community has a major involvement in the process.

• Conduct product safety assessments for new and existing products and their constituents to ensure their safety and compliance with regulatory requirements prior to market introduction.

• Develop appropriate toxicological testing strategies for product evaluations, select appropriate laboratories for monitoring, monitor laboratory studies, evaluate the resulting data, and prepare documents for submission to EPA and FDA for approval.

• Interface with EPA and FDA to ensure that all questions and issues regarding technical issues associated with new and existing product registrations are adequately addressed and resolved based on good science.

• Evaluate new data published in the scientific literature on materials relating to new or existing products for their scientific validity and for their potential impact on new and existing product approval cycles.

• Review product dossiers for consistency with newly acquired data, and to determine whether the regulatory requirements of new markets can be met with existing data. Interface with product development teams in the EEC, Japan, and Latin America to ensure compliance with regulatory requirements in all markets.

TYPICAL PROJECTS COMPLETED

• Conducted numerous human health risk assessments under RCRA, CERCLA, CAA, and state environmental statutes including the RCRA Human Health Risk Assessments for both on-shore and off-shore media for the Portsmouth Naval Shipyard, Kittery, Maine.

• Conducted a RCRA Human Health Risk Assessment for Off-Shore exposures to the Piscataqua River, adjacent to the Portsmouth Naval Shipyard, including risks from ingestion of lobster, mussels, and flounder.

• Successfully negotiated USEPA approval for Risk-Based Media Protection Standards for cleanup of air, groundwater, and surface soil for Portsmouth Naval Shipyard, based on human health risks which are specific to the facility.

• Successfully negotiated USEPA approval for establishing groundwater cleanup levels based on ecological impacts, without the need to consider future residential use of groundwater at a CERCLA site.

• Successfully negotiated USEPA approval for establishing soil and air cleanup levels based on industrial exposures, without the need to assume future residential exposures, for an active CERCLA facility.

• Successfully negotiated USEPA approval for a soil lead cleanup value based on site-specific information, for a CERCLA site.

• Served as an expert witness for USEPA in several litigations involving potential human health risks associated with major releases of highly toxic chemicals in high profile cases involving PCBs.

• Served as an expert witness for USEPA in litigations involving the potential human health risks associated with indirect exposures to chemicals released as the result of combustion of hazardous waste.

• Conducted technical reviews of human health risk assesssment documents for USEPA Regions 1, 2, 3, 4, and 5 to determine whether documents submitted by regulated parties were in compliance with USEPA and state approved methodologies for conducting risk assessments, and for their technical accuracy.

• Provided technical oversight for USEPA for a Multipathway Human Health Risk Assessment, conducted to evaluate the potential health impacts through indirect exposure pathways, of emissions from a hazardous waste incinerator.

• Completed more than 100 product safety assessments. Designed testing schemes, monitored laboratory studies, evaluated resulting data, documented results and conclusions, and prepared documents for submission to EPA for registration.

• Established procedures for the evaluation of chemicals for genetic toxicology, qualified laboratories for their expertise in this area, and implemented these procedures for Xerox Corporation.

• Conducted a critical review of the genetic toxicology data contained in the product dossier of a widely used pesticide for a large pesticide manufacturer. Prepared a technical response to issues raised by EPA and prepared a manuscript for publication of these data.

• Established procedures for conducting human health risk assessments for product exposures and occupational exposures for Xerox Corporation. Reviewed documents prepared by junior scientists for generation of MSDSs and for compliance with labeling requirements. Participated on corporate committee which developed corporate policies on Environmental Health and Safety.

PUBLICATIONS AND PRESENTATIONS

1. Mahoney, E.M., "Risk Assessment Review for Pennsylvania’s Land Recycling Program." Invited speaker, Pennsylvania Department of Environmental Protection (PADEP) Land Recycling and Cleanup Program, Harrisburg, 1997.

2. Mahoney, E.M., "Risk Assessment : The Basics of Practice and Procedure", Invited speaker, EPAPR Meeting, Philadelphia, 1997.

3. Mahoney, E.M., Risk-Based Remediation Is Cost Effective, EPAPR Newsletter, Vol 2, No.3, 1997

4. Mahoney, E.M., Risk-Based Remediation Enables Better Cleanup Solutions, Pennsylvania’s Environment, December, 1995.

5. Mahoney, E.M., A Review of Seafood Ingestion Rates Utilized by Various Agencies for Assessing Human Health Risks Associated with Ingesting Contaminated Seafood, presented at Society for Risk Analysis Annual Meeting, Honolulu, 1995.

6. Mahoney, E.M., Human Health Risk Assessment for Off-Shore Media at Portsmouth Naval Shipyard, presented at Society of Environmental Toxicology and Chemistry Annual Meeting, Vancouver, Canada, 1995.

7. Mahoney, E.M., Draft Media Protection Standards for On-Shore Media, presented at Community Public Meeting, Kittery, Maine, 1995.

8. Mahoney, E.M., Sayers, K.S., and Urschel, S.F., An Analysis of the Impact of Potential Off-Shore Releases form a RCRA Facility on Risks Associated with Ingestion of Seafood for the Local Population, presented at Society for Risk Analysis Annual Meeting, Savannah, 1993.

9. Mahoney, E.M., Proposed Media Protection Standards for On-Shore Media Based on Human Health Risk Assessment for Portsmouth Naval Shipyard, presented at Technical Review Committee Meeting, Kittery, Maine, 1993.

10. Mahoney, E.M., Public Health and Environmental Risk Evaluation for the Portsmouth Naval Shipyard Part 2: Human Health Risk Assessment Off-Shore Results, presented at Technical Review Committee Meeting, Kittery, Maine, 1993.

11. Mahoney, E.M., Public Health and Environmental Evaluation: On-Shore Human Health Risk Assessment at Portsmouth Naval Shipyard, presented at Community Public Meeting, Kittery, Maine, 1993.

12. Mahoney, E.M., Public Health and Environmental Risk Evaluation for the Portsmouth Naval Shipyard Part 1: On-Shore Results, presented at Technical Review Committee Meeting, Kittery, Maine, 1993.

13. Mahoney, E.M. and Medcalf, A.S., Case Study: The Use of Risk Assessment in Establishing Media Protection Standards Under RCRA Corrective Action, presented at Society for Risk Analysis Annual Meeting, San Diego, 1992.

14. Mahoney, E.M. and Medcalf, A.S., Use of the US Environmental Protection Agency’s Lead Model for Establishing Soil Cleanup levels at a Hazardous Waste Site, presented at Royal Society of Chemistry Meeting, London, UK, 1992.

15. Mahoney, E.M., Interim Human Health Risk Assessment at Quarters S,N, and 68. Portsmouth Naval Shipyard, presented at Technical Review Committee Meeting, Kittery, Maine, 1991.

16. Mahoney, E.M., Interim Human Health Risk Assessment for Child Day Care Center Portsmouth Naval Shipyard, presented at Technical Review Committee Meeting, Kittery, Maine, 1991.

17. Mahoney, E.M., The Use of USEPA’s Lead Uptake Biokinetic Model for Setting Soil Cleanup Levels at a Superfund Site, presented at Society for Risk Analysis Annual Meeting, Baltimore, 1991.

18. Lin, G.H., Mahoney, E.M., and Marsh, D.G., Mutagenicity Studies on Two Chromium III Coordination Compounds, Environmental and Molecular Mutagenesis, Vol 17, Suppl 19, Abs 146, 1991.

19. Mahoney, E.M., Ball, J., Richmond, D., Swenson, D., Maher, V.M., and McCormick, J.J., Cytotoxicity and Mutagenicity of Aflatoxin Dichloride in Normal and Repair-Deficient Diploid Human Fibroblasts, presented at Environmental Mutagen Society Annual Meeting, Montreal, 1984.

20. Mahoney, E.M., Ball, J., Swenson, D., Richmond, D., Maher, V.M., and McCormick, J.J., Cytotoxicity and Mutagenicity of Aflatoxin Dichloride in Normal and Repair-Deficient Diploid Human Fibroblasts, Chem-Biological Interactions, 50, 59-76, 1984.